)
)
Applying Different Omics Technologies to Predict Adverse Outcomes in Pregnancy
-
Using metabolomics and RNA sequencing at four different time points in pregnancy to find predictive biomarkers for adverse events e.g. still birth, preeclampsia and gestational diabetes.
-
Measuring ctRNA in different samples such as blood, plasma and paternal DNA.
-
Approaching the study design
-
Translational applications and driving omics testing into the clinic.
-
Moving towards proteomics, epigenetics and a multi-omics approach.
